A subjective visual sensation with the eyes closed and in the absence of light. Phosphenes can be spontaneous, or induced by chemical, electrical, or mechanical (pressure) stimuli which cause the visual field to light up without optical inputs.
Artificial device such as an externally-worn camera attached to a stimulator on the RETINA, OPTIC NERVE, or VISUAL CORTEX, intended to restore or amplify vision.
Skills in the use of language which lead to proficiency in written or spoken communication.
A technique that involves the use of electrical coils on the head to generate a brief magnetic field which reaches the CEREBRAL CORTEX. It is coupled with ELECTROMYOGRAPHY response detection to assess cortical excitability by the threshold required to induce MOTOR EVOKED POTENTIALS. This method is also used for BRAIN MAPPING, to study NEUROPHYSIOLOGY, and as a substitute for ELECTROCONVULSIVE THERAPY for treating DEPRESSION. Induction of SEIZURES limits its clinical usage.
Area of the OCCIPITAL LOBE concerned with the processing of visual information relayed via VISUAL PATHWAYS.
The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.
Devices that help people with impaired sensory responses.
The selecting and organizing of visual stimuli based on the individual's past experience.
Artificial substitutes for body parts, and materials inserted into tissue for functional, cosmetic, or therapeutic purposes. Prostheses can be functional, as in the case of artificial arms and legs, or cosmetic, as in the case of an artificial eye. Implants, all surgically inserted or grafted into the body, tend to be used therapeutically. IMPLANTS, EXPERIMENTAL is available for those used experimentally.
Posterior portion of the CEREBRAL HEMISPHERES responsible for processing visual sensory information. It is located posterior to the parieto-occipital sulcus and extends to the preoccipital notch.
The minimum amount of stimulus energy necessary to elicit a sensory response.
Abnormal formation of blood vessels that shunt arterial blood directly into veins without passing through the CAPILLARIES. They usually are crooked, dilated, and with thick vessel walls. A common type is the congenital arteriovenous fistula. The lack of blood flow and oxygen in the capillaries can lead to tissue damage in the affected areas.
Use of electric potential or currents to elicit biological responses.

Retinal ganglion cell response properties in the transcorneal electrically evoked response of the visual system. (1/66)

To identify the retinal origin of a cortical evoked potential elicited by transcorneal electrical stimulation of the visual system (EER), the response properties of retinal ganglion cells (RGCs) of cats to transcorneal electrical stimuli were studied. The discharge latency of RGCs to transcorneal stimulation had two peaks with a high temporal resolution. The latency of early components of the EER is associated with the discharge latency of RGCs. Some RGCs showed prominent oscillatory discharges after transcorneal stimulation. Discharges of ON-bipolar cells responding to transcorneal stimulation were significantly inhibited by intravitreal injection of DL-2-amino-4-phosphonobutyrate (APB), which blocks the ON-pathway. These findings indicate that the EER has far-field potentials that might relate to oscillatory discharges of RGCs, and that ON bipolar cells and their related synaptic sites are involved in transcorneal electrical stimuli. The far-field potentials of the EER may have clinical applications, similar to those of somatosensoric evoked potentials and auditory brain stem potentials.  (+info)

A neural interface for a cortical vision prosthesis. (2/66)

The development of a cortically based vision prosthesis has been hampered by a lack of basic experiments on phosphene psychophysics. This basic research has been hampered by the lack of a means to safely stimulate large numbers of cortical neurons. Recently, a number of laboratories have developed arrays of silicon microelectrodes that could enable such basic studies on phosphene psychophysics. This paper describes one such array, the Utah electrode array, and summarizes neurosurgical, physiological and histological experiments that suggest that such an array could be implanted safely in visual cortex. We also summarize a series of chronic behavioral experiments that show that modest levels of electrical currents passed into cortex via this array can evoke sensory percepts. Pending the successful outcome of biocompatibility studies using such arrays, high count arrays of penetrating microelectrodes similar to this design could provide a useful tool for studies of the psychophysics of phosphene perception in human volunteers. Such studies could provide a proof-of-concept for cortically based artificial vision.  (+info)

Enhanced excitability of the human visual cortex induced by short-term light deprivation. (3/66)

Long-term deprivation of visual input for several days or weeks leads to marked changes in the excitability and function of the occipital cortex. The time course of these changes is poorly understood. In this study, we addressed the question whether a short period of light deprivation (minutes to a few hours) can elicit such changes in humans. Noninvasive transcranial magnetic stimulation (TMS) of the human occipital cortex can evoke the perception of flashes or spots of light (phosphenes). To assess changes in visual cortex excitability following light deprivation, we measured the minimum intensity of stimulation required to elicit phosphenes (phosphene threshold) and the number of phosphenes elicited by different TMS stimulus intensities (stimulus-response curves). A reduced phosphene threshold was detected 45 min after the onset of light deprivation and persisted for the entire deprivation period (180 min). Following re-exposure to light, phosphene thresholds returned to predeprivation values over 120 min. Stimulus-response curves were significantly enhanced in association with this intervention. In a second experiment, we studied the effects of light deprivation on functional magnetic resonance imaging (fMRI) signals elicited by photic stimulation. fMRI results showed increased visual cortex activation after 60 min of light deprivation that persisted following 30 min of re-exposure to light. Our results demonstrated a substantial increase in visual cortex excitability. These changes may underlie behavioral gains reported in humans and animals associated with light deprivation.  (+info)

Electrical stimulation of anterior visual pathways in retinitis pigmentosa. (4/66)

PURPOSE: To explore electrically induced phosphenes in blind patients with retinitis pigmentosa (RP) in comparison with healthy subjects and to develop a screening test for candidates for an optic nerve visual prosthesis implantation. METHODS: Phosphenes are obtained by charge balanced biphasic pulse stimulations through a surface cathode over the closed eyelids and an anode near the opposite ear. The resulting strength-duration relationship for somatosensory, phosphene, and pain threshold has been recorded in five RP patients as well as in 10 healthy volunteers. RESULTS: In sighted subjects, the average rheobase and chronaxy for phosphene perception are 0.28 mA and 3.07 msec, respectively. For pulse durations longer than 2 msec, phosphenes are usually obtained at current strengths below the level giving rise to any other electrically generated sensation. In RP patients, however, phosphenes are not so easily obtained. One in five had no visual response at all. Another patient reported a flash perception for the longest pulse durations only. Spontaneous phosphenes interfered heavily with the stimulation in a third person. Finally, despite the higher threshold, two patients displayed normally shaped strength-duration curves. CONCLUSIONS: The surface stimulation has proven harmless, adequate, and very helpful to ascertain that the optic nerve can be electrically activated in completely blind individuals. Long-duration stimulation pulses yield very low phosphene thresholds in healthy subjects. Anterior visual pathways activation requires higher currents in RP patients.  (+info)

Fast backprojections from the motion to the primary visual area necessary for visual awareness. (5/66)

Much is known about the pathways from photoreceptors to higher visual areas in the brain. However, how we become aware of what we see or of having seen at all is a problem that has eluded neuroscience. Recordings from macaque V1 during deactivation of MT+/V5 and psychophysical studies of perceptual integration suggest that feedback from secondary visual areas to V1 is necessary for visual awareness. We used transcranial magnetic stimulation to probe the timing and function of feedback from human area MT+/V5 to V1 and found its action to be early and critical for awareness of visual motion.  (+info)

Changes in visual cortex excitability in blind subjects as demonstrated by transcranial magnetic stimulation. (6/66)

Any attempt to restore visual functions in blind subjects with pregeniculate lesions provokes the question of the extent to which deafferented visual cortex is still able to generate conscious visual experience. As a simple approach to assessing activation of the visual cortex, subjects can be asked to report conscious subjective light sensations (phosphenes) elicited by focal transcranial magnetic stimulation (TMS) over the occiput. We hypothesized that such induction of phosphenes can be used as an indicator of residual function of the visual cortex and studied 35 registered blind subjects after partial or complete long-term (>10 years) deafferentation of the visual cortex due to pregeniculate lesions. TMS was applied over the visual cortex in 10 blind subjects with some residual vision (visual acuity <20/400; Group 1), 15 blind subjects with very poor residual vision (only perception of movement or light; Group 2), 10 blind subjects without any residual vision (Group 3) and 10 healthy controls. A stimulation mapping procedure was performed on a 1 x 1 cm skull surface grid with 130 stimulation points overlying the occipital skull. We analysed the occurrence of phosphenes at each stimulation point with regard to frequency and location of phosphenes in the visual field. Previous experiments have shown that repetitive TMS reliably elicits brief flashes of white or coloured patches of light. Therefore, stimulation was performed with short trains of seven consecutive 15 Hz stimuli applied with an intensity of 1.3 times the motor threshold. Under such conditions, phosphenes occurred in 100% of subjects in Group 1, in 60% of Group 2 and in 20% of Group 3. Phosphene thresholds were normal, but the number of effective stimulation sites was significantly reduced in Groups 2 and 3. The results indicate that in blind subjects there is alteration in TMS-induced activation of the deafferented visual cortex or processes engaged in bringing the artificial cortex input to consciousness. The ability to elicit phosphenes is reduced in subjects with a high degree of visual deafferentation, especially in those without previous visual experience.  (+info)

Effects of repetitive transcranial magnetic stimulation on visual evoked potentials in migraine. (7/66)

Between attacks, migraine patients are characterized by potentiation instead of habituation of stimulation-evoked cortical responses. It is debated whether this is due to increased or decreased cortical excitability. We have studied the changes in visual cortex excitability by recording pattern-reversal visual evoked potentials (PR-VEP) after low- and high-frequency repetitive transcranial magnetic stimulation (rTMS), known respectively for their inhibitory and excitatory effect on the cortex. In 30 patients (20 migraine without, 10 with aura) and 24 healthy volunteers, rTMS of the occipital cortex was performed with a focal figure-of-eight magnetic coil (Magstim). Nine hundred pulses were delivered randomly at 1 or 10 Hz in two separate sessions. Stimulus intensity was set to the phosphene threshold or to 110% of the motor threshold if no phosphenes were elicited. Before and after rTMS, PR-VEP were averaged sequentially in six blocks of 100zztieresponses during uninterrupted 3.1 Hz stimulation. In healthy volunteers, PR-VEP amplitude was significantly decreased in the first block after 1 Hz rTMS and the habituation normally found in successive blocks after sustained stimulation was significantly attenuated. In migraine patients, 10 Hz rTMS was followed by a significant increase of first block PR-VEP amplitude and by a reversal to normal habituation of the potentiation (or dishabituation) characteristic of the disorder. This effect was similar in both forms of migraine and lasted for at least 9 min. There were no significant changes of PR-VEP amplitudes after 1 Hz rTMS in migraineurs and after 10 Hz rTMS in healthy volunteers, nor after sham stimulation. The recovery of a normal PR-VEP habituation pattern after high-frequency rTMS is probably due to activation of the visual cortex and the dishabituation in healthy volunteers to cortical inhibition. We conclude, therefore, that the deficient interictal PR-VEP habituation in migraine is due to a reduced, and not to an increased, pre-activation excitability level of the visual cortex.  (+info)

Position, size and luminosity of phosphenes generated by direct optic nerve stimulation. (8/66)

Pulses of low intensity current, delivered through a cuff electrode chronically implanted around the optic nerve of a blind retinitis pigmentosa patient generate visual sensations. These phosphenes are obtained at lower thresholds for a train of stimuli than for single pulses, which suggests the existence of a spatial and temporal integrating mechanism. The perceptions are much smaller than those predicted from model simulations. A set of equations are derived which show the effect of pulse current, duration, number and frequency on the position, size and, to some extent, luminosity of the resulting phosphenes.  (+info)

Phosphenes are described as the phenomenon of seeing light without light actually entering the eye. This can occur through various mechanisms such as applying pressure to the eyeball, due to rubbing or closing the eyes tightly, or after exposure to bright lights. Additionally, phosphenes can also be experienced during conditions like migraines or as a result of certain neurological disorders.

In simpler terms, phosphenes are the sensation of seeing flashes of light caused by internal stimuli rather than external light input.

A visual prosthesis, also known as a retinal implant or bionic eye, is a medical device that aims to restore some functional vision in individuals who have severe visual impairment or blindness due to certain eye conditions such as retinitis pigmentosa or age-related macular degeneration.

The prosthesis works by electrically stimulating the remaining viable nerve cells in the retina, which then transmit the signals to the brain via the optic nerve. The device typically consists of a camera that captures visual information, a processor that converts the images into electrical signals, and an electrode array that is implanted onto the surface of the retina.

The electrical stimulation of the retinal cells creates patterns of light in the individual's visual field, allowing them to perceive shapes, edges, and movements. While the level of visual acuity achieved with current visual prostheses is still limited, they can significantly improve the quality of life for some individuals by enabling them to perform tasks such as recognizing objects, navigating their environment, and identifying facial expressions.

I'm sorry for any confusion, but "Language Arts" is not a term used in medical definitions. Language arts is a term commonly used in education to refer to the academic study of reading, writing, speaking, and listening. It encompasses various subjects such as English, literature, grammar, creative writing, and communication skills. If you have any questions related to medical terminology or health-related topics, I would be happy to help with those!

Transcranial Magnetic Stimulation (TMS) is a non-invasive form of brain stimulation where a magnetic field is generated via an electromagnetic coil placed on the scalp. This magnetic field induces an electric current in the underlying brain tissue, which can lead to neuronal activation or inhibition, depending on the frequency and intensity of the stimulation. TMS has been used as a therapeutic intervention for various neurological and psychiatric conditions, such as depression, migraine, and tinnitus, among others. It is also used in research settings to investigate brain function and connectivity.

The visual cortex is the part of the brain that processes visual information. It is located in the occipital lobe, which is at the back of the brain. The visual cortex is responsible for receiving and interpreting signals from the retina, which are then transmitted through the optic nerve and optic tract.

The visual cortex contains several areas that are involved in different aspects of visual processing, such as identifying shapes, colors, and movements. These areas work together to help us recognize and understand what we see. Damage to the visual cortex can result in various visual impairments, such as blindness or difficulty with visual perception.

Blindness is a condition of complete or near-complete vision loss. It can be caused by various factors such as eye diseases, injuries, or birth defects. Total blindness means that a person cannot see anything at all, while near-complete blindness refers to having only light perception or the ability to perceive the direction of light, but not able to discern shapes or forms. Legal blindness is a term used to define a certain level of visual impairment that qualifies an individual for government assistance and benefits; it usually means best corrected visual acuity of 20/200 or worse in the better eye, or a visual field no greater than 20 degrees in diameter.

Sensory aids are devices or equipment that are used to improve or compensate for impaired sensory functions such as hearing, vision, or touch. They are designed to help individuals with disabilities or impairments to better interact with their environment and perform daily activities. Here are some examples:

1. Hearing aids - electronic devices worn in or behind the ear that amplify sounds for people with hearing loss.
2. Cochlear implants - surgically implanted devices that provide sound sensations to individuals with severe to profound hearing loss.
3. Visual aids - devices used to improve vision, such as eyeglasses, contact lenses, magnifiers, or telescopic lenses.
4. Low vision devices - specialized equipment for people with significant visual impairment, including large print books, talking watches, and screen readers.
5. Tactile aids - devices that provide tactile feedback to individuals with visual or hearing impairments, such as Braille displays or vibrating pagers.

Overall, sensory aids play an essential role in enhancing the quality of life for people with sensory impairments by improving their ability to communicate, access information, and navigate their environment.

Visual perception refers to the ability to interpret and organize information that comes from our eyes to recognize and understand what we are seeing. It involves several cognitive processes such as pattern recognition, size estimation, movement detection, and depth perception. Visual perception allows us to identify objects, navigate through space, and interact with our environment. Deficits in visual perception can lead to learning difficulties and disabilities.

Prostheses: Artificial substitutes or replacements for missing body parts, such as limbs, eyes, or teeth. They are designed to restore the function, appearance, or mobility of the lost part. Prosthetic devices can be categorized into several types, including:

1. External prostheses: Devices that are attached to the outside of the body, like artificial arms, legs, hands, and feet. These may be further classified into:
a. Cosmetic or aesthetic prostheses: Primarily designed to improve the appearance of the affected area.
b. Functional prostheses: Designed to help restore the functionality and mobility of the lost limb.
2. Internal prostheses: Implanted artificial parts that replace missing internal organs, bones, or tissues, such as heart valves, hip joints, or intraocular lenses.

Implants: Medical devices or substances that are intentionally placed inside the body to replace or support a missing or damaged biological structure, deliver medication, monitor physiological functions, or enhance bodily functions. Examples of implants include:

1. Orthopedic implants: Devices used to replace or reinforce damaged bones, joints, or cartilage, such as knee or hip replacements.
2. Cardiovascular implants: Devices that help support or regulate heart function, like pacemakers, defibrillators, and artificial heart valves.
3. Dental implants: Artificial tooth roots that are placed into the jawbone to support dental prostheses, such as crowns, bridges, or dentures.
4. Neurological implants: Devices used to stimulate nerves, brain structures, or spinal cord tissues to treat various neurological conditions, like deep brain stimulators for Parkinson's disease or cochlear implants for hearing loss.
5. Ophthalmic implants: Artificial lenses that are placed inside the eye to replace a damaged or removed natural lens, such as intraocular lenses used in cataract surgery.

The occipital lobe is the portion of the cerebral cortex that lies at the back of the brain (posteriorly) and is primarily involved in visual processing. It contains areas that are responsible for the interpretation and integration of visual stimuli, including color, form, movement, and recognition of objects. The occipital lobe is divided into several regions, such as the primary visual cortex (V1), secondary visual cortex (V2 to V5), and the visual association cortex, which work together to process different aspects of visual information. Damage to the occipital lobe can lead to various visual deficits, including blindness or partial loss of vision, known as a visual field cut.

Sensory thresholds are the minimum levels of stimulation that are required to produce a sensation in an individual, as determined through psychophysical testing. These tests measure the point at which a person can just barely detect the presence of a stimulus, such as a sound, light, touch, or smell.

There are two types of sensory thresholds: absolute and difference. Absolute threshold is the minimum level of intensity required to detect a stimulus 50% of the time. Difference threshold, also known as just noticeable difference (JND), is the smallest change in intensity that can be detected between two stimuli.

Sensory thresholds can vary between individuals and are influenced by factors such as age, attention, motivation, and expectations. They are often used in clinical settings to assess sensory function and diagnose conditions such as hearing or vision loss.

Arteriovenous malformations (AVMs) are abnormal tangles of blood vessels that directly connect arteries and veins, bypassing the capillary system. This results in a high-flow and high-pressure circulation in the affected area. AVMs can occur anywhere in the body but are most common in the brain and spine. They can vary in size and may cause symptoms such as headaches, seizures, or bleeding in the brain. In some cases, AVMs may not cause any symptoms and may only be discovered during imaging tests for other conditions. Treatment options include surgery, radiation therapy, or embolization to reduce the flow of blood through the malformation and prevent complications.

Electric stimulation, also known as electrical nerve stimulation or neuromuscular electrical stimulation, is a therapeutic treatment that uses low-voltage electrical currents to stimulate nerves and muscles. It is often used to help manage pain, promote healing, and improve muscle strength and mobility. The electrical impulses can be delivered through electrodes placed on the skin or directly implanted into the body.

In a medical context, electric stimulation may be used for various purposes such as:

1. Pain management: Electric stimulation can help to block pain signals from reaching the brain and promote the release of endorphins, which are natural painkillers produced by the body.
2. Muscle rehabilitation: Electric stimulation can help to strengthen muscles that have become weak due to injury, illness, or surgery. It can also help to prevent muscle atrophy and improve range of motion.
3. Wound healing: Electric stimulation can promote tissue growth and help to speed up the healing process in wounds, ulcers, and other types of injuries.
4. Urinary incontinence: Electric stimulation can be used to strengthen the muscles that control urination and reduce symptoms of urinary incontinence.
5. Migraine prevention: Electric stimulation can be used as a preventive treatment for migraines by applying electrical impulses to specific nerves in the head and neck.

It is important to note that electric stimulation should only be administered under the guidance of a qualified healthcare professional, as improper use can cause harm or discomfort.

No FAQ available that match "phosphenes"

No images available that match "phosphenes"